Ajooni Biotech Limited (AJOONI.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-900.0%

-₹23.20

vs ₹2.90 price

Levered DCF

-₹29.21

After debt service

Piotroski score

6 / 9

Average

Altman Z-score

3.15

Safe zone

Rating

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	42.67×	33.78×	24.64×	14.5×	58.11×	92.4×	20.89×	32.48×
P/B	2.02×	1.26×	1.26×	0.39×	3.62×	2.2×	0.46×	1.14×
P/S	1.01×	0.97×	0.67×	0.22×	0.8×	0.68×	0.18×	0.35×
EV / EBITDA	32.25×	18.43×	12.56×	6.85×	20.77×	28.59×	10.59×	13.5×
Gross margin	15.2%	12.0%	12.2%	11.7%	13.5%	15.7%	12.8%	8.2%
Operating margin	2.2%	2.3%	1.9%	2.4%	2.7%	2.4%	1.9%	0.8%
Net margin	2.4%	2.8%	2.7%	1.5%	1.4%	0.7%	0.9%	1.0%
Current ratio	2.72×	12.86×	10.74×	2.28×	2.18×	2.05×	3×	6.14×
Debt / equity	0.19×	0.02×	0.05×	0.12×	0.33×	0.43×	0.32×	0.06×
Interest coverage	5.55×	7.76×	2.72×	3.69×	3.66×	2.08×	2.44×	2.88×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	4.7%	3.7%	5.1%	2.7%	6.4%	2.4%	2.2%	3.4%
Return on invested capital	2.8%	2.2%	2.4%	2.7%	6.5%	4.0%	2.6%	1.6%
Return on assets	3.6%	3.4%	4.5%	1.9%	3.6%	1.3%	1.5%	2.3%
Free cash flow yield	-12.6%	-17.3%	-17.7%	-52.4%	2.6%	-6.9%	-79.9%	-37.7%
Earnings yield	2.3%	2.9%	4.0%	7.0%	1.8%	1.1%	4.8%	3.0%
Enterprise value	₹2B	₹1.1B	₹556M	₹209.7M	₹646.4M	₹410.3M	₹121.5M	₹138.5M
Net debt / EBITDA	2.77×	-0.85×	0.39×	1.59×	1.7×	4.56×	4.27×	0.04×
Cash conversion cycle (days)	136	168	131	84	63	98	132	84